Diagnosis and Treatment of Lung Cancer Complicated with Sepsis from Perspective of "Yang Wei Yin Xian" Theory

LIU Qinghua; ZHU Rui; YAN Jun

doi:10.3971/j.issn.1000-8578.2025.25.0030

Cancer Research on Prevention and Treatment > 2025 > 52(5): 423-428. > DOI: 10.3971/j.issn.1000-8578.2025.25.0030

LIU Qinghua, ZHU Rui, YAN Jun. Diagnosis and Treatment of Lung Cancer Complicated with Sepsis from Perspective of "Yang Wei Yin Xian" Theory[J]. Cancer Research on Prevention and Treatment, 2025, 52(5): 423-428. DOI: 10.3971/j.issn.1000-8578.2025.25.0030

Citation:

PDF (592 KB)

Diagnosis and Treatment of Lung Cancer Complicated with Sepsis from Perspective of "Yang Wei Yin Xian" Theory

LIU Qinghua^1, ,,
ZHU Rui^1,,
YAN Jun^{1, 2, , ,}

1.
Department of Pulmonary, Beijing Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China
2.
Institute of Sepsis, Beijing University of Chinese Medicine, Beijing 100700, China

Funding:

undefined

Capital’s Funds for Health Improvement and Research (No. 2020-2-4192); Dongzhimen Hospital Science and Technology Innovation Project (No. DZMKJCX-2020-027)

More Information

Corresponding author:
YAN Jun, E-mail: dzmyyyj@126.com
Received Date: January 09, 2025
Revised Date: February 14, 2025
Accepted Date: March 23, 2025
Available Online: March 26, 2025

Graphical Abstract

Abstract

Abstract

"Yang Wei Yin Xian" originates from "Jin Kui Yao Lue". It denotes the slight pulse at the cun pulse and the yin pulse in the yang position, which indicates a deficiency of yang qi in the upper focus. The ulnar vein is a cord, and the yin position corresponds to the yin vein, which is excessive yin pathogen in the lower jiao. Lung cancer complicated with sepsis is common in clinical practice; it is characterized by a high mortality rate and poor conventional treatment outcomes. This article discusses "Yang Wei Yin Xian" and its relationship with lung cancer complicated by sepsis, evaluates the selection of TCM prescriptions and efficacy mechanisms of "Yang Wei Yin Xian" theory, and provides a reference for the use of this theory to guide clinical treatment.
- Yang Wei Yin Xian,
- Sepsis,
- Lung cancer,
- Pathogenesis

FullText(HTML)

Competing interests: The authors declare that they have no competing interests.

References (47)

References

[1]	Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.
[2]	Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management[J]. BMJ, 2016, 353: i1585.
[3]	Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
[4]	Shvetsov YB, Ogino MH, Glibetic N, et al. Association of Sepsis Mortality with Specific Cancer Sites and Treatment Type: The Multiethnic Cohort Study[J]. J Pers Med, 2021, 11(2): 146.
[5]	Wu XQ, Li JY, Du WJ. Causes of death following small cell lung cancer diagnosis: a population-based analysis[J]. BMC Pulm Med, 2022, 22(1): 262.
[6]	张秀强, 杨涛. 基于列线图模型对肺癌胸腔镜术后并发肺部感染的临床预测[J]. 肿瘤防治研究, 2023, 50(1): 52-57. [Zhang XQ, Yang T. Clinical prediction of lung cancer complicated with pulmonary infection after thoracoscopic surgery based on nomogram model[J]. Zhong Liu Fang Zhi Yan Jiu, 2023, 50(1): 52-57.] doi: 10.3971/j.issn.1000-8578.2023.22.0585 Zhang XQ, Yang T. Clinical prediction of lung cancer complicated with pulmonary infection after thoracoscopic surgery based on nomogram model[J]. Zhong Liu Fang Zhi Yan Jiu, 2023, 50(1): 52-57. doi: 10.3971/j.issn.1000-8578.2023.22.0585
[7]	谢朝云, 覃家露, 熊芸, 等. 晚期肺癌患者肺部感染死亡危险因素分析[J]. 肿瘤防治研究, 2018, 45(4): 221-224. [Xie ZY, Qin JL, Xiong Y, et al. Risk factors for death of advanced lung cancer patients with lung infection[J]. Zhong Liu Fang Zhi Yan Jiu, 2018, 45(4): 221-224.] doi: 10.3971/j.issn.1000-8578.2018.17.0993 Xie ZY, Qin JL, Xiong Y, et al. Risk factors for death of advanced lung cancer patients with lung infection[J]. Zhong Liu Fang Zhi Yan Jiu, 2018, 45(4): 221-224. doi: 10.3971/j.issn.1000-8578.2018.17.0993
[8]	Isono T, Iwahori K, Yanagawa M, et al. T cell immunity in interstitial lung disease with non-small cell lung cancer patients[J]. Lung Cancer, 2023, 182: 107278.
[9]	杨泽利, 周庆涛, 孙永昌. 血清肺癌标志物水平与脓毒症病情和预后的相关性[J]. 中华医院感染学杂志, 2022, 32(3): 360-364. [Yang ZL, Zhou QT, Sun YC, et al. Correlation of serum lung cancer biomarkers with the severity and prognosis of sepsis[J]. Zhonghua Yi Yuan Gan Ran Xue Za Zhi, 2022, 32(3): 360-364.] Yang ZL, Zhou QT, Sun YC, et al. Correlation of serum lung cancer biomarkers with the severity and prognosis of sepsis[J]. Zhonghua Yi Yuan Gan Ran Xue Za Zhi, 2022, 32(3): 360-364.
[10]	袁晓雨, 李艳丽. 血清MMP-9、sTREM-1、CRP、PCT水平联合应用对肺癌化疗并发细菌性肺部感染的诊断价值[J]. 辽宁医学杂志, 2024, 38(6): 6-9. [Yan XY, Li YL. The diagnostic value of combined application of serum MMP-9, sTREM-1, CRP, and PCT levels in lung cancer chemotherapy complicated with bacterial lung infection[J]. Liaoning Yi Xue Za Zhi, 2024, 38(6): 6-9.] Yan XY, Li YL. The diagnostic value of combined application of serum MMP-9, sTREM-1, CRP, and PCT levels in lung cancer chemotherapy complicated with bacterial lung infection[J]. Liaoning Yi Xue Za Zhi, 2024, 38(6): 6-9.
[11]	于天良, 沈丽梅. 血清PCT、SAA及ACE2对非小细胞肺癌患者化疗期间肺部感染的鉴别诊断价值分析[J]. 中华养生保健, 2024, 42(23): 192-196. [Yu TL, Shen LM. Analysis of the Differential Diagnostic Value of Serum PCT, SAA, and ACE2 in Lung Infection During Chemotherapy in Non-small Cell Lung Cancer Patients[J]. Zhonghua Yang Sheng Bao Jian, 2024, 42(23): 192-196.] Yu TL, Shen LM. Analysis of the Differential Diagnostic Value of Serum PCT, SAA, and ACE2 in Lung Infection During Chemotherapy in Non-small Cell Lung Cancer Patients[J]. Zhonghua Yang Sheng Bao Jian, 2024, 42(23): 192-196.
[12]	翁羽, 阎其均, 胡梅霞, 等. 肺癌合并肺部感染病原菌与耐药性及外周血TLR2和TLR4表达水平[J]. 中华医院感染学杂志, 2024(24): 3693-3697. [Wen Y, Yan QJ, Hu MX, et al. Pathogenic bacteria, drug resistance and expression of TLR2 and TLR4 in patients with lung cancer complicated by pulmonary infection[J]. Zhonghua Yi Yuan Gan Ran Xue Za Zhi, 2024(24): 3693-3697.] Wen Y, Yan QJ, Hu MX, et al. Pathogenic bacteria, drug resistance and expression of TLR2 and TLR4 in patients with lung cancer complicated by pulmonary infection[J]. Zhonghua Yi Yuan Gan Ran Xue Za Zhi, 2024(24): 3693-3697.
[13]	刘金玉, 钟祖军, 谢春芳. 降钙素原、中性粒细胞CD64、内毒素检测联合细菌培养对化疗后脓毒症诊断的价值[J]. 河北医药, 2019, 41(2): 240-243. [Liu JY, Zhong ZJ, Xie CF. The value of procalcitonin, neutrophil CD64, endotoxin detection combined with bacterial culture in diagnosis of sepsis after chemotherapy in patients with non small cell lung cancer[J]. Hebei Yi Yao, 2019, 41(2): 240-243.] Liu JY, Zhong ZJ, Xie CF. The value of procalcitonin, neutrophil CD64, endotoxin detection combined with bacterial culture in diagnosis of sepsis after chemotherapy in patients with non small cell lung cancer[J]. Hebei Yi Yao, 2019, 41(2): 240-243.
[14]	李霖, 徐自强, 乐冬友, 等. 脓毒症患者血TLR4、PTX3、Apelin的水平变化及其与病情、预后的关系[J]. 中国医师杂志, 2021, 23(9): 1357-1361. [Li L, Xu ZQ, Le DY, et al. Changes of serum TLR4, PTX3 and Apelin expression in patients with sepsis and their relationship with condition and prognosis[J]. Zhongguo Yi Shi Za Zhi, 2021, 23(9): 1357-1361.] doi: 10.3760/cma.j.cn431274-20200709-00945 Li L, Xu ZQ, Le DY, et al. Changes of serum TLR4, PTX3 and Apelin expression in patients with sepsis and their relationship with condition and prognosis[J]. Zhongguo Yi Shi Za Zhi, 2021, 23(9): 1357-1361. doi: 10.3760/cma.j.cn431274-20200709-00945
[15]	Suresh K, Naidoo J, Lin CT, et al. Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities[J]. Chest, 2018, 154(6): 1416-1423. doi: 10.1016/j.chest.2018.08.1048
[16]	王菁, 李杰, 李晓敏, 等. 10212例原发性肺癌患者临床流行病学特征及预测模型构建[J]. 中华肿瘤防治杂志, 2024, 31(22): 1354-1360. [Wang J, Li J, Li XM, et al. Clinical epidemiological distribution characteristics in 10212 primary lung cancer patients and construction of prediction model[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2024, 31(22): 1354-1360.] Wang J, Li J, Li XM, et al. Clinical epidemiological distribution characteristics in 10212 primary lung cancer patients and construction of prediction model[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2024, 31(22): 1354-1360.
[17]	陈修园. 金匮要略浅注·金匮要略方歌括[M]. 山西: 山西科学技术出版社, 2013: 60. [Chen XY. Light Note on Essentials of The Golden Cabint·Medicinal Formulae in Poetic Version Essentials of The Golden Cabint[M]. Shanxi: Shanxi Science and Technology Publishing House, 2013: 60.] Chen XY. Light Note on Essentials of The Golden Cabint·Medicinal Formulae in Poetic Version Essentials of The Golden Cabint[M]. Shanxi: Shanxi Science and Technology Publishing House, 2013: 60.
[18]	王玉兴. 金匮要略三家注[M]. 北京: 中国中医药出版社, 2013: 125. [Wang YX. Note on Essentials of The Golden Cabint[M]. Beijing: China Press of Traditional Chinese Medicine, 2013: 125.] Wang YX. Note on Essentials of The Golden Cabint[M]. Beijing: China Press of Traditional Chinese Medicine, 2013: 125.
[19]	王西墨, 余剑波, 金胜威. 脓毒症肺损伤中西医结合诊治专家共识[J]. 中国中西医结合外科杂志, 2020, 26(3): 400-408. [Wang XM, Yu JB, Jin SW. Expert consensus on the diagnosis and treatment of sepsis lung injury with integrated traditional Chinese and Western medicine[J]. Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi, 2020, 26(3): 400-408.] doi: 10.3969/j.issn.1007-6948.2020.03.002 Wang XM, Yu JB, Jin SW. Expert consensus on the diagnosis and treatment of sepsis lung injury with integrated traditional Chinese and Western medicine[J]. Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi, 2020, 26(3): 400-408. doi: 10.3969/j.issn.1007-6948.2020.03.002
[20]	魏一鸣, 徐霄龙, 胡雅慧, 等. 基于数据挖掘的某中医院重症医学科治疗脓毒症的中药组方规律分析[J]. 环球中医药, 2024, 17(2): 248-255. [Wei YM, Xu XL, Hu YH, et al. Analysis on the rule of TCM formulation in the treatment of sepsis in intensive care department of a hospital of Traditional Chinese Medicine based on data mining[J]. Huan Qiu Zhong Yi Yao, 2024, 17(2): 248-255.] Wei YM, Xu XL, Hu YH, et al. Analysis on the rule of TCM formulation in the treatment of sepsis in intensive care department of a hospital of Traditional Chinese Medicine based on data mining[J]. Huan Qiu Zhong Yi Yao, 2024, 17(2): 248-255.
[21]	卢彩云, 刘畅, 黄敏, 等. 人参皂苷Rb1调控线粒体自噬对脓毒症血管内皮的保护作用及其机制研究[J]. 疑难病杂志, 2024, 23(10): 1246-1251. [Lu CY, Liu C, Huang M, et al. The protective effects and mechanisms of ginsenoside Rb1 on vascular endothelium of sepsis by regulating mitophagy[J]. Yi Nan Bing Za Zhi, 2024, 23(10): 1246-1251.] doi: 10.3969/j.issn.1671-6450.2024.10.017 Lu CY, Liu C, Huang M, et al. The protective effects and mechanisms of ginsenoside Rb1 on vascular endothelium of sepsis by regulating mitophagy[J]. Yi Nan Bing Za Zhi, 2024, 23(10): 1246-1251. doi: 10.3969/j.issn.1671-6450.2024.10.017
[22]	李国臣, 王为为, 张文昭, 等. 人参皂苷Rg1对脓毒症器官损害保护作用的研究进展[J]. 中国中医急症, 2024, 33(8): 1488-1491. [Li GC, Wang WW, Zhang WZ, et al. Research progress on the protective effect of ginsenoside Rg1 on organ damage in sepsis[J]. Zhongguo Zhong Yi Ji Zheng, 2024, 33(8): 1488-1491.] doi: 10.3969/j.issn.1004-745X.2024.08.045 Li GC, Wang WW, Zhang WZ, et al. Research progress on the protective effect of ginsenoside Rg1 on organ damage in sepsis[J]. Zhongguo Zhong Yi Ji Zheng, 2024, 33(8): 1488-1491. doi: 10.3969/j.issn.1004-745X.2024.08.045
[23]	黄健, 徐佳, 范婧婧, 等. 甘草酸靶向干预高迁移率族蛋白1抑制炎症相关疾病的研究进展[J]. 中国新药杂志, 2024, 33(4): 345-350. [Huang J, Xu J, Fan JJ, et al. Progress in pharmacological studies on glycyrrhizic acid to attenuate inflammation-mediated diseases by inhibiting HMGB1[J]. Zhongguo Xin Yao Za Zhi, 2024, 33(4): 345-350.] Huang J, Xu J, Fan JJ, et al. Progress in pharmacological studies on glycyrrhizic acid to attenuate inflammation-mediated diseases by inhibiting HMGB1[J]. Zhongguo Xin Yao Za Zhi, 2024, 33(4): 345-350.
[24]	师帅, 宋庆桥, 吴华芹, 等. “桂枝-白芍”药对作用机制的网络药理学研究[J]. 北京中医药, 2020, 39(12): 1275-1280. [Shi S, Song QQ, Wu HQ, et al. Study of mechanism of paired drugs of Cinnamomi Ramulus and Paeoniae Radix Alba based on network pharmacology[J]. Beijing Zhong Yi Yao, 2020, 39(12): 1275-1280.] Shi S, Song QQ, Wu HQ, et al. Study of mechanism of paired drugs of Cinnamomi Ramulus and Paeoniae Radix Alba based on network pharmacology[J]. Beijing Zhong Yi Yao, 2020, 39(12): 1275-1280.
[25]	杨清鑫, 吕红君, 王小博, 等. 基于整合药理学平台的桂枝-白芍药对抗脓毒症的分子机制研究[J]. 中国中药杂志, 2019, 44(13): 2691-2700. [Yang QX, Lyu HJ, Wang XB, et al. Molecular mechanism of Cinnamomi Ramulus-Paeoniae Radix Alba drug pair against sepsis based on integrative pharmacology platform of traditional Chinese medicine[J]. Zhongguo Zhong Yao Za Zhi, 2019, 44(13): 2691-2700.] Yang QX, Lyu HJ, Wang XB, et al. Molecular mechanism of Cinnamomi Ramulus-Paeoniae Radix Alba drug pair against sepsis based on integrative pharmacology platform of traditional Chinese medicine[J]. Zhongguo Zhong Yao Za Zhi, 2019, 44(13): 2691-2700.
[26]	陈凯立, 王婷, 罗智浩. 山茱萸新苷介导NF-κB/NLRP3通路对脓毒症大鼠肠黏膜屏障的影响[J]. 中国医师杂志, 2024, 26(10): 1488-1494. [Chen KL, Wang T, Luo ZH, et al. The effect of cornus officinalis glycoside on the intestinal mucosal barrier of septic rats by regulating the NF-κB/NLRP3 pathway[J]. Zhongguo Yi Shi Za Zhi, 2024, 26(10): 1488-1494.] doi: 10.3760/cma.j.cn431274-20231224-00713 Chen KL, Wang T, Luo ZH, et al. The effect of cornus officinalis glycoside on the intestinal mucosal barrier of septic rats by regulating the NF-κB/NLRP3 pathway[J]. Zhongguo Yi Shi Za Zhi, 2024, 26(10): 1488-1494. doi: 10.3760/cma.j.cn431274-20231224-00713
[27]	赵进喜, 张立山, 张保春, 等. 人参黄芪, 益气可培元;麦冬阿胶, 养阴能存津[J]. 环球中医药, 2019, 12(6): 875-877. [Zhao JX, Zhang LS, Zhang BC, et al. Ginseng astragalus, invigorating qi can be peiyuan; Mai Dong Ejiao, nourishing yin can save Jin[J]. Huan Qiu Zhong Yi Yao, 2019, 12(6): 875-877.] doi: 10.3969/j.issn.1674-1749.2019.06.012 Zhao JX, Zhang LS, Zhang BC, et al. Ginseng astragalus, invigorating qi can be peiyuan; Mai Dong Ejiao, nourishing yin can save Jin[J]. Huan Qiu Zhong Yi Yao, 2019, 12(6): 875-877. doi: 10.3969/j.issn.1674-1749.2019.06.012
[28]	万梅绪, 原景, 张燕欣, 等. 麦冬提取物及其有效成分的药理作用研究进展[J]. 药物评价研究, 2023, 46(8): 1819-1826. [Wan MX, Yan J, Zhang YX, et al. Research progress on pharmacological effects of extracts and active components of Ophiopogon japonicus[J]. Yao Wu Ping Jia Yan Jiu, 2023, 46(8): 1819-1826.] Wan MX, Yan J, Zhang YX, et al. Research progress on pharmacological effects of extracts and active components of Ophiopogon japonicus[J]. Yao Wu Ping Jia Yan Jiu, 2023, 46(8): 1819-1826.
[29]	喻明, 李晓斌, 李翔宇, 等. 百合地黄汤及其类方在肿瘤治疗中的应用[J]. 实用中医内科杂志, 2024, 38(2): 100-102. [Yu M, Li XB, Li XY, et al. Application of Baihe Dihuang Decoction and Its Analogues in Treatment of Tumors[J]. Shi Yong Zhong Yi Nei Ke Za Zhi, 2024, 38(2): 100-102.] Yu M, Li XB, Li XY, et al. Application of Baihe Dihuang Decoction and Its Analogues in Treatment of Tumors[J]. Shi Yong Zhong Yi Nei Ke Za Zhi, 2024, 38(2): 100-102.
[30]	单贝贝, 谢颖桢, 牛丽强, 等. 基于“卫气营血”理论辨治脓毒症相关性脑病经验[J]. 北京中医药, 2024, 43(6): 707-709. [Shan BB, Xie YZ, Niu LQ, et al. Experience in differentiating syndrome and treating sepsis related encephalopathy based on the theory of "Wei defence Qi, Ying nutrient blood"[J]. Beijing Zhong Yi Yao, 2024, 43(6): 707-709.] Shan BB, Xie YZ, Niu LQ, et al. Experience in differentiating syndrome and treating sepsis related encephalopathy based on the theory of "Wei defence Qi, Ying nutrient blood"[J]. Beijing Zhong Yi Yao, 2024, 43(6): 707-709.
[31]	钟洁, 潘兴邦, 顾伟. 急诊脓毒症脑病临床诊疗及预后分析[J]. 中国医师杂志, 2023, 25(4): 551-554. [Zhong J, Pan XB, Gu W. Clinical diagnosis and prognosis analysis in patients with emergency septic encephalopathy[J]. Zhongguo Yi Shi Za Zhi, 2023, 25(4): 551-554.] doi: 10.3760/cma.j.cn431274-20230202-00083 Zhong J, Pan XB, Gu W. Clinical diagnosis and prognosis analysis in patients with emergency septic encephalopathy[J]. Zhongguo Yi Shi Za Zhi, 2023, 25(4): 551-554. doi: 10.3760/cma.j.cn431274-20230202-00083
[32]	张博, 梁玉宁, 鲍友利, 等. 基于网络药理学和实验验证探究经典药对“瓜蒌-薤白”治疗痰瘀互结心血管疾病的作用机制[J]. 药学学报, 2023, 58(6): 1452-1463. [Zhang B, Liang YN, Bao YL, et al. The mechanism of "Trichosanthis Fructus-Allii Macrostemonis Bulbus" on phlegm and blood stasis syndrome-related cardiovascular diseases based on network pharmacology and experimental verification[J]. Yao Xue Xue Bao, 2023, 58(6): 1452-1463.] Zhang B, Liang YN, Bao YL, et al. The mechanism of "Trichosanthis Fructus-Allii Macrostemonis Bulbus" on phlegm and blood stasis syndrome-related cardiovascular diseases based on network pharmacology and experimental verification[J]. Yao Xue Xue Bao, 2023, 58(6): 1452-1463.
[33]	黄洋, 袁思成, 芮庆林. 基于圆运动古中医学理论辨析多器官功能障碍综合征[J]. 河北中医, 2020, 42(11): 1731-1735. [Huang Y, Yuan SC, Rui QL. Analysis of multiple organ dysfunction syndrome based on the theory of circular motion in ancient Chinese medicine[J]. Hebei Zhong Yi, 2020, 42(11): 1731-1735.] doi: 10.3969/j.issn.1002-2619.2020.11.030 Huang Y, Yuan SC, Rui QL. Analysis of multiple organ dysfunction syndrome based on the theory of circular motion in ancient Chinese medicine[J]. Hebei Zhong Yi, 2020, 42(11): 1731-1735. doi: 10.3969/j.issn.1002-2619.2020.11.030
[34]	崔向君, 陈加敏, 孔立, 等. 中医药治疗脓毒症相关急性肾损伤的研究进展[J]. 中国中医急症, 2024, 33(9): 1685-1688. [Cui XJ, Chen JM, Kong L, et al. Research progress of traditional Chinese medicine in the treatment of sepsis-related acute kidney injury[J]. Zhongguo Zhong Yi Ji Zheng, 2024, 33(9): 1685-1688.] doi: 10.3969/j.issn.1004-745X.2024.09.045 Cui XJ, Chen JM, Kong L, et al. Research progress of traditional Chinese medicine in the treatment of sepsis-related acute kidney injury[J]. Zhongguo Zhong Yi Ji Zheng, 2024, 33(9): 1685-1688. doi: 10.3969/j.issn.1004-745X.2024.09.045
[35]	樊雅欣, 沈洁, 唐剑飞, 等. 中西医结合治疗恶性胸腔积液的研究进展[J]. 中国中医急症, 2024, 33(2): 352-356. [Fan YX, Shen J, Tang JF, et al. Research progress of integrated traditional Chinese and Western medicine in the treatment of malignant pleural effusion[J]. Zhongguo Zhong Yi Ji Zheng, 2024, 33(2): 352-356.] doi: 10.3969/j.issn.1004-745X.2024.02.043 Fan YX, Shen J, Tang JF, et al. Research progress of integrated traditional Chinese and Western medicine in the treatment of malignant pleural effusion[J]. Zhongguo Zhong Yi Ji Zheng, 2024, 33(2): 352-356. doi: 10.3969/j.issn.1004-745X.2024.02.043
[36]	顾国祥, 栗昀, 王凡. 附子“破癥坚积聚”功效探讨[J]. 中医学报, 2024, 39(11): 2376-2380. [Gu GX, Li Y, Wang F. Discussion on Fuzi (Monkshood) in "Treating Mass in Abdomen"[J]. Zhong Yi Xue Bao, 2024, 39(11): 2376-2380.] Gu GX, Li Y, Wang F. Discussion on Fuzi (Monkshood) in "Treating Mass in Abdomen"[J]. Zhong Yi Xue Bao, 2024, 39(11): 2376-2380.
[37]	秦晓颖, 陈文静, 刘玉萍, 等. 和厚朴酚与厚朴酚治疗免疫紊乱疾病及其免疫调控作用研究进展[J]. 中草药, 2024, 55(24): 8602-8612. [Qin XY, Chen WJ, Liu YP, et al. Research progress on treatment of immune-disordered diseases and their immunomodulatory effects[J]. Zhong Cao Yao, 2024, 55(24): 8602-8612.] Qin XY, Chen WJ, Liu YP, et al. Research progress on treatment of immune-disordered diseases and their immunomodulatory effects[J]. Zhong Cao Yao, 2024, 55(24): 8602-8612.
[38]	郭禹航, 陈虎, 苏钊, 等. 肺癌的中医病机、防治及治法探析: 从六经辨证角度[J]. 亚太传统医药, 2024, 20(11): 199-203. [Guo YH, Chen H, Su Z, et al. Research progress on treatment of immune-disordered diseases and their immunomodulatory effects by honokiol and magnolol[J]. Ya Tai Chuan Tong Yi Yao, 2024, 20(11): 199-203.] Guo YH, Chen H, Su Z, et al. Research progress on treatment of immune-disordered diseases and their immunomodulatory effects by honokiol and magnolol[J]. Ya Tai Chuan Tong Yi Yao, 2024, 20(11): 199-203.
[39]	印佩如, 倪海滨. 中西医结合治疗脓毒症毛细血管渗漏综合征的研究进展[J]. 中国中医药现代远程教育, 2022, 20(18): 206-208. [Yin PR, Ni HB. Research Progress of Integrated Traditional Chinese and Western Medicine in the Treatment of Capillary Leakage Syndrome of Sepsis[J]. Zhongguo Zhong Yi Yao Xian Dai Yuan Cheng Jiao Yu, 2022, 20(18): 206-208.] doi: 10.3969/j.issn.1672-2779.2022.18.068 Yin PR, Ni HB. Research Progress of Integrated Traditional Chinese and Western Medicine in the Treatment of Capillary Leakage Syndrome of Sepsis[J]. Zhongguo Zhong Yi Yao Xian Dai Yuan Cheng Jiao Yu, 2022, 20(18): 206-208. doi: 10.3969/j.issn.1672-2779.2022.18.068
[40]	贾臻, 任小清, 任杰. 枳实薤白桂枝汤联合低分子肝素治疗肺栓塞临床研究[J]. 河南中医, 2017, 37(2): 210-212. [Jia Z, Ren XQ, Ren J. Clinical Research on Pulmonary Embolism Treated with Immature Bitter Orange, Chinese Chive and Cinnamon Twig Decoction Combined with Low-Molecular Heparin[J]. He′nan Zhong Yi, 2017, 37(2): 210-212.] Jia Z, Ren XQ, Ren J. Clinical Research on Pulmonary Embolism Treated with Immature Bitter Orange, Chinese Chive and Cinnamon Twig Decoction Combined with Low-Molecular Heparin[J]. He′nan Zhong Yi, 2017, 37(2): 210-212.
[41]	杨文刚. 桂枝茯苓丸加减对提高肺癌手术效果的对比研究[J]. 中外医疗, 2017, 36(31): 160-162. [Yang WG. Research on Comparison of Modified Guizhi Fuling Pill in Improving the Operative Effect of Lung Cancer[J]. Zhong Wai Yi Liao, 2017, 36(31): 160-162.] Yang WG. Research on Comparison of Modified Guizhi Fuling Pill in Improving the Operative Effect of Lung Cancer[J]. Zhong Wai Yi Liao, 2017, 36(31): 160-162.
[42]	苏家卉, 吴彩军, 南富耀, 等. 基于网络药理学探讨丹皮-赤芍药对治疗脓毒症的作用机制[J]. 中国医师杂志, 2023, 25(2): 178-185. [Su JH, Wu CJ, Nan FY, et al. Study on the mechanism of Danpi-Chishao in the treatment of sepsis based on network pharmacology[J]. Zhongguo Yi Shi Za Zhi, 2023, 25(2): 178-185.] doi: 10.3760/cma.j.cn431274-20230204-00093 Su JH, Wu CJ, Nan FY, et al. Study on the mechanism of Danpi-Chishao in the treatment of sepsis based on network pharmacology[J]. Zhongguo Yi Shi Za Zhi, 2023, 25(2): 178-185. doi: 10.3760/cma.j.cn431274-20230204-00093
[43]	金力, 何健卓, 尹鑫, 等. 基于“毒、虚、瘀”探讨脓毒症血管内皮细胞损伤与微循环障碍[J]. 中国中西医结合杂志, 2024, 44(11): 1391-1395. [Jin L, He JZ, Yin X, et al. Investigation of Vascular Endothelial Cell Injury and Microcirculation Disturbance in Sepsis Based on "Toxicity, Deficiency and Stasis"[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2024, 44(11): 1391-1395.] Jin L, He JZ, Yin X, et al. Investigation of Vascular Endothelial Cell Injury and Microcirculation Disturbance in Sepsis Based on "Toxicity, Deficiency and Stasis"[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2024, 44(11): 1391-1395.
[44]	蔡云, 陈远彬, 叶放, 等. 国医大师周仲瑛从癌毒理论辨治肺癌经验述要[J]. 中华中医药杂志, 2020, 35(6): 2879-2882. [Cai Y, Chen YB, Ye F, et al. Brief on TCM master ZHOU Zhong-ying's experience in the treatment of lung cancer based on cancerous toxin theory[J]. Zhonghua Zhong Yi Yao Za Zhi, 2020, 35(6): 2879-2882.] Cai Y, Chen YB, Ye F, et al. Brief on TCM master ZHOU Zhong-ying's experience in the treatment of lung cancer based on cancerous toxin theory[J]. Zhonghua Zhong Yi Yao Za Zhi, 2020, 35(6): 2879-2882.
[45]	Wang Y, Sun N, Luo Y, et al. Yu-Ping-Feng Formula Exerts Antilung Cancer Effects by Remodeling the Tumor Microenvironment through Regulating Myeloid-Derived Suppressor Cells[J]. Evid Based Complement Alternat Med, 2021, 2021: 6624461.
[46]	张维骏, 侯建春, 王艳, 等. 路志正运用益肺化积汤治疗肺癌经验[J]. 中医杂志, 2018, 59(4): 289-291. [Zhang WJ, Hou JC, Wang Y, et al. LU Zhizheng's Experiences in Treating Lung Cancer with Yifei Huaji Decoction[J]. Zhong Yi Za Zhi, 2018, 59(4): 289-291.] Zhang WJ, Hou JC, Wang Y, et al. LU Zhizheng's Experiences in Treating Lung Cancer with Yifei Huaji Decoction[J]. Zhong Yi Za Zhi, 2018, 59(4): 289-291.
[47]	刘艺, 吴彩军, 李春盛. 中西医结合临床治疗脓毒症的一点思考[J]. 中国医师杂志, 2022, 24(4): 481-485. [Liu Y, Wu CJ, Li CS. Some thoughts on treating sepsis with integrated traditional Chinese and Western medicine[J]. Zhongguo Yi Shi Za Zhi, 2022, 24(4): 481-485.] doi: 10.3760/cma.j.cn431274-20220214-00092 Liu Y, Wu CJ, Li CS. Some thoughts on treating sepsis with integrated traditional Chinese and Western medicine[J]. Zhongguo Yi Shi Za Zhi, 2022, 24(4): 481-485. doi: 10.3760/cma.j.cn431274-20220214-00092

Cited By

Get Citation

PDF

XML

Article views (1091) PDF downloads (302)

Turn off MathJax

Article Contents

Abstract

References

Diagnosis and Treatment of Lung Cancer Complicated with Sepsis from Perspective of "Yang Wei Yin Xian" Theory

Abstract

References

Catalog

Download Center

Links

Contact Us

Diagnosis and Treatment of Lung Cancer Complicated with Sepsis from Perspective of "Yang Wei Yin Xian" Theory

Abstract

References

Catalog

Download Center

Links

Contact Us

Export File

Citation

Format

Content